MaxCyte (MXCT) (GB:MXCT) has released an update.
MaxCyte, Inc., a pioneer in cell-engineering platform technologies, has announced its upcoming Annual General Meeting (AGM) scheduled for June 11, 2024. Aimed at advancing next-generation cell therapeutics, the company’s AGM will take place at its Maryland headquarters, with relevant documents available on MaxCyte’s website. The company continues to innovate in the cell therapy market with its ExPERT platform, providing partners with comprehensive technology and support.
For further insights into GB:MXCT stock, check out TipRanks’ Stock Analysis page.
